The global Diabetic Retinopathy market is projected to grow from US$ 8302.3 million in 2023 to US$ 11920 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.

Diabetic Retinopathy Market

Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.

Market Analysis and Insights: Global Diabetic Retinopathy Market

Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.

Report Includes

This report presents an overview of global market for Diabetic Retinopathy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Diabetic Retinopathy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Diabetic Retinopathy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Diabetic Retinopathy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Diabetic Retinopathy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Diabetic Retinopathy revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bayer, Roche, Novartis, TEVA, Alimera Sciences, Regeneron Pharmaceuticals, Boehringer Ingelheim, Kowa Group and Ohr Pharmaceutical, etc.

Scope of Diabetic Retinopathy Market Report

Report Metric	Details
Report Name	Diabetic Retinopathy Market
Accounted market size in 2023	US$ 8302.3 million
Forecasted market size in 2029	US$ 11920 million
CAGR	6.2
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Laser Surgery Injection of Corticosteroids Anti-VEGF Drugs Vitrectomy
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Bayer, Roche, Novartis, TEVA, Alimera Sciences, Regeneron Pharmaceuticals, Boehringer Ingelheim, Kowa Group, Ohr Pharmaceutical, Quark Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Diabetic Retinopathy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Retinopathy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetic Retinopathy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Diabetic Retinopathy Market growing?

Ans: The Diabetic Retinopathy Market witnessing a CAGR of 6.2 during the forecast period 2023-2029.

What is the Diabetic Retinopathy Market size in 2029?

Ans: The global Diabetic Retinopathy market is projected to grow from US$ 8302.3 million in 2023 to US$ 11920 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Diabetic Retinopathy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Laser Surgery

1.2.3 Injection of Corticosteroids

1.2.4 Anti-VEGF Drugs

1.2.5 Vitrectomy

1.3 Market by Application

1.3.1 Global Diabetic Retinopathy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetic Retinopathy Market Perspective (2018-2029)

2.2 Global Diabetic Retinopathy Growth Trends by Region

2.2.1 Diabetic Retinopathy Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Diabetic Retinopathy Historic Market Size by Region (2018-2023)

2.2.3 Diabetic Retinopathy Forecasted Market Size by Region (2024-2029)

2.3 Diabetic Retinopathy Market Dynamics

2.3.1 Diabetic Retinopathy Industry Trends

2.3.2 Diabetic Retinopathy Market Drivers

2.3.3 Diabetic Retinopathy Market Challenges

2.3.4 Diabetic Retinopathy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Diabetic Retinopathy by Players

3.1.1 Global Diabetic Retinopathy Revenue by Players (2018-2023)

3.1.2 Global Diabetic Retinopathy Revenue Market Share by Players (2018-2023)

3.2 Global Diabetic Retinopathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Diabetic Retinopathy, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Diabetic Retinopathy Market Concentration Ratio

3.4.1 Global Diabetic Retinopathy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Diabetic Retinopathy Revenue in 2022

3.5 Global Key Players of Diabetic Retinopathy Head office and Area Served

3.6 Global Key Players of Diabetic Retinopathy, Product and Application

3.7 Global Key Players of Diabetic Retinopathy, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Diabetic Retinopathy Breakdown Data by Type

4.1 Global Diabetic Retinopathy Historic Market Size by Type (2018-2023)

4.2 Global Diabetic Retinopathy Forecasted Market Size by Type (2024-2029)

5 Diabetic Retinopathy Breakdown Data by Application

5.1 Global Diabetic Retinopathy Historic Market Size by Application (2018-2023)

5.2 Global Diabetic Retinopathy Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Diabetic Retinopathy Market Size (2018-2029)

6.2 North America Diabetic Retinopathy Market Size by Type

6.2.1 North America Diabetic Retinopathy Market Size by Type (2018-2023)

6.2.2 North America Diabetic Retinopathy Market Size by Type (2024-2029)

6.2.3 North America Diabetic Retinopathy Market Share by Type (2018-2029)

6.3 North America Diabetic Retinopathy Market Size by Application

6.3.1 North America Diabetic Retinopathy Market Size by Application (2018-2023)

6.3.2 North America Diabetic Retinopathy Market Size by Application (2024-2029)

6.3.3 North America Diabetic Retinopathy Market Share by Application (2018-2029)

6.4 North America Diabetic Retinopathy Market Size by Country

6.4.1 North America Diabetic Retinopathy Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Diabetic Retinopathy Market Size by Country (2018-2023)

6.4.3 North America Diabetic Retinopathy Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Diabetic Retinopathy Market Size (2018-2029)

7.2 Europe Diabetic Retinopathy Market Size by Type

7.2.1 Europe Diabetic Retinopathy Market Size by Type (2018-2023)

7.2.2 Europe Diabetic Retinopathy Market Size by Type (2024-2029)

7.2.3 Europe Diabetic Retinopathy Market Share by Type (2018-2029)

7.3 Europe Diabetic Retinopathy Market Size by Application

7.3.1 Europe Diabetic Retinopathy Market Size by Application (2018-2023)

7.3.2 Europe Diabetic Retinopathy Market Size by Application (2024-2029)

7.3.3 Europe Diabetic Retinopathy Market Share by Application (2018-2029)

7.4 Europe Diabetic Retinopathy Market Size by Country

7.4.1 Europe Diabetic Retinopathy Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Diabetic Retinopathy Market Size by Country (2018-2023)

7.4.3 Europe Diabetic Retinopathy Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Diabetic Retinopathy Market Size (2018-2029)

8.2 China Diabetic Retinopathy Market Size by Type

8.2.1 China Diabetic Retinopathy Market Size by Type (2018-2023)

8.2.2 China Diabetic Retinopathy Market Size by Type (2024-2029)

8.2.3 China Diabetic Retinopathy Market Share by Type (2018-2029)

8.3 China Diabetic Retinopathy Market Size by Application

8.3.1 China Diabetic Retinopathy Market Size by Application (2018-2023)

8.3.2 China Diabetic Retinopathy Market Size by Application (2024-2029)

8.3.3 China Diabetic Retinopathy Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Diabetic Retinopathy Market Size (2018-2029)

9.2 Asia Diabetic Retinopathy Market Size by Type

9.2.1 Asia Diabetic Retinopathy Market Size by Type (2018-2023)

9.2.2 Asia Diabetic Retinopathy Market Size by Type (2024-2029)

9.2.3 Asia Diabetic Retinopathy Market Share by Type (2018-2029)

9.3 Asia Diabetic Retinopathy Market Size by Application

9.3.1 Asia Diabetic Retinopathy Market Size by Application (2018-2023)

9.3.2 Asia Diabetic Retinopathy Market Size by Application (2024-2029)

9.3.3 Asia Diabetic Retinopathy Market Share by Application (2018-2029)

9.4 Asia Diabetic Retinopathy Market Size by Region

9.4.1 Asia Diabetic Retinopathy Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Diabetic Retinopathy Market Size by Region (2018-2023)

9.4.3 Asia Diabetic Retinopathy Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Type

10.2.1 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Diabetic Retinopathy Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Application

10.3.1 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Diabetic Retinopathy Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Country

10.4.1 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Bayer

11.1.1 Bayer Company Details

11.1.2 Bayer Business Overview

11.1.3 Bayer Diabetic Retinopathy Introduction

11.1.4 Bayer Revenue in Diabetic Retinopathy Business (2018-2023)

11.1.5 Bayer Recent Developments

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Diabetic Retinopathy Introduction

11.2.4 Roche Revenue in Diabetic Retinopathy Business (2018-2023)

11.2.5 Roche Recent Developments

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Diabetic Retinopathy Introduction

11.3.4 Novartis Revenue in Diabetic Retinopathy Business (2018-2023)

11.3.5 Novartis Recent Developments

11.4 TEVA

11.4.1 TEVA Company Details

11.4.2 TEVA Business Overview

11.4.3 TEVA Diabetic Retinopathy Introduction

11.4.4 TEVA Revenue in Diabetic Retinopathy Business (2018-2023)

11.4.5 TEVA Recent Developments

11.5 Alimera Sciences

11.5.1 Alimera Sciences Company Details

11.5.2 Alimera Sciences Business Overview

11.5.3 Alimera Sciences Diabetic Retinopathy Introduction

11.5.4 Alimera Sciences Revenue in Diabetic Retinopathy Business (2018-2023)

11.5.5 Alimera Sciences Recent Developments

11.6 Regeneron Pharmaceuticals

11.6.1 Regeneron Pharmaceuticals Company Details

11.6.2 Regeneron Pharmaceuticals Business Overview

11.6.3 Regeneron Pharmaceuticals Diabetic Retinopathy Introduction

11.6.4 Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2018-2023)

11.6.5 Regeneron Pharmaceuticals Recent Developments

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Details

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Diabetic Retinopathy Introduction

11.7.4 Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2018-2023)

11.7.5 Boehringer Ingelheim Recent Developments

11.8 Kowa Group

11.8.1 Kowa Group Company Details

11.8.2 Kowa Group Business Overview

11.8.3 Kowa Group Diabetic Retinopathy Introduction

11.8.4 Kowa Group Revenue in Diabetic Retinopathy Business (2018-2023)

11.8.5 Kowa Group Recent Developments

11.9 Ohr Pharmaceutical

11.9.1 Ohr Pharmaceutical Company Details

11.9.2 Ohr Pharmaceutical Business Overview

11.9.3 Ohr Pharmaceutical Diabetic Retinopathy Introduction

11.9.4 Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2018-2023)

11.9.5 Ohr Pharmaceutical Recent Developments

11.10 Quark Pharmaceuticals

11.10.1 Quark Pharmaceuticals Company Details

11.10.2 Quark Pharmaceuticals Business Overview

11.10.3 Quark Pharmaceuticals Diabetic Retinopathy Introduction

11.10.4 Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2018-2023)

11.10.5 Quark Pharmaceuticals Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Regeneron Pharmaceuticals

Boehringer Ingelheim

Kowa Group

Ohr Pharmaceutical

Quark Pharmaceuticals

List of Tables

Table 1. Global Diabetic Retinopathy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Laser Surgery

Table 3. Key Players of Injection of Corticosteroids

Table 4. Key Players of Anti-VEGF Drugs

Table 5. Key Players of Vitrectomy

Table 6. Global Diabetic Retinopathy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 7. Global Diabetic Retinopathy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 8. Global Diabetic Retinopathy Market Size by Region (2018-2023) & (US$ Million)

Table 9. Global Diabetic Retinopathy Market Share by Region (2018-2023)

Table 10. Global Diabetic Retinopathy Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 11. Global Diabetic Retinopathy Market Share by Region (2024-2029)

Table 12. Diabetic Retinopathy Market Trends

Table 13. Diabetic Retinopathy Market Drivers

Table 14. Diabetic Retinopathy Market Challenges

Table 15. Diabetic Retinopathy Market Restraints

Table 16. Global Diabetic Retinopathy Revenue by Players (2018-2023) & (US$ Million)

Table 17. Global Diabetic Retinopathy Revenue Share by Players (2018-2023)

Table 18. Global Top Diabetic Retinopathy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy as of 2022)

Table 19. Global Diabetic Retinopathy Industry Ranking 2021 VS 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by Diabetic Retinopathy Revenue (CR5 and HHI) & (2018-2023)

Table 21. Global Key Players of Diabetic Retinopathy, Headquarters and Area Served

Table 22. Global Key Players of Diabetic Retinopathy, Product and Application

Table 23. Global Key Players of Diabetic Retinopathy, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Diabetic Retinopathy Market Size by Type (2018-2023) & (US$ Million)

Table 26. Global Diabetic Retinopathy Revenue Market Share by Type (2018-2023)

Table 27. Global Diabetic Retinopathy Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 28. Global Diabetic Retinopathy Revenue Market Share by Type (2024-2029)

Table 29. Global Diabetic Retinopathy Market Size by Application (2018-2023) & (US$ Million)

Table 30. Global Diabetic Retinopathy Revenue Share by Application (2018-2023)

Table 31. Global Diabetic Retinopathy Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 32. Global Diabetic Retinopathy Revenue Share by Application (2024-2029)

Table 33. North America Diabetic Retinopathy Market Size by Type (2018-2023) & (US$ Million)

Table 34. North America Diabetic Retinopathy Market Size by Type (2024-2029) & (US$ Million)

Table 35. North America Diabetic Retinopathy Market Size by Application (2018-2023) & (US$ Million)

Table 36. North America Diabetic Retinopathy Market Size by Application (2024-2029) & (US$ Million)

Table 37. North America Diabetic Retinopathy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. North America Diabetic Retinopathy Market Size by Country (2018-2023) & (US$ Million)

Table 39. North America Diabetic Retinopathy Market Size by Country (2024-2029) & (US$ Million)

Table 40. Europe Diabetic Retinopathy Market Size by Type (2018-2023) & (US$ Million)

Table 41. Europe Diabetic Retinopathy Market Size by Type (2024-2029) & (US$ Million)

Table 42. Europe Diabetic Retinopathy Market Size by Application (2018-2023) & (US$ Million)

Table 43. Europe Diabetic Retinopathy Market Size by Application (2024-2029) & (US$ Million)

Table 44. Europe Diabetic Retinopathy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 45. Europe Diabetic Retinopathy Market Size by Country (2018-2023) & (US$ Million)

Table 46. Europe Diabetic Retinopathy Market Size by Country (2024-2029) & (US$ Million)

Table 47. China Diabetic Retinopathy Market Size by Type (2018-2023) & (US$ Million)

Table 48. China Diabetic Retinopathy Market Size by Type (2024-2029) & (US$ Million)

Table 49. China Diabetic Retinopathy Market Size by Application (2018-2023) & (US$ Million)

Table 50. China Diabetic Retinopathy Market Size by Application (2024-2029) & (US$ Million)

Table 51. Asia Diabetic Retinopathy Market Size by Type (2018-2023) & (US$ Million)

Table 52. Asia Diabetic Retinopathy Market Size by Type (2024-2029) & (US$ Million)

Table 53. Asia Diabetic Retinopathy Market Size by Application (2018-2023) & (US$ Million)

Table 54. Asia Diabetic Retinopathy Market Size by Application (2024-2029) & (US$ Million)

Table 55. Asia Diabetic Retinopathy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 56. Asia Diabetic Retinopathy Market Size by Region (2018-2023) & (US$ Million)

Table 57. Asia Diabetic Retinopathy Market Size by Region (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Type (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Type (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Application (2018-2023) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Application (2024-2029) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Diabetic Retinopathy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 63. Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Country (2018-2023) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Diabetic Retinopathy Market Size by Country (2024-2029) & (US$ Million)

Table 65. Bayer Company Details

Table 66. Bayer Business Overview

Table 67. Bayer Diabetic Retinopathy Product

Table 68. Bayer Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 69. Bayer Recent Developments

Table 70. Roche Company Details

Table 71. Roche Business Overview

Table 72. Roche Diabetic Retinopathy Product

Table 73. Roche Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 74. Roche Recent Developments

Table 75. Novartis Company Details

Table 76. Novartis Business Overview

Table 77. Novartis Diabetic Retinopathy Product

Table 78. Novartis Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 79. Novartis Recent Developments

Table 80. TEVA Company Details

Table 81. TEVA Business Overview

Table 82. TEVA Diabetic Retinopathy Product

Table 83. TEVA Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 84. TEVA Recent Developments

Table 85. Alimera Sciences Company Details

Table 86. Alimera Sciences Business Overview

Table 87. Alimera Sciences Diabetic Retinopathy Product

Table 88. Alimera Sciences Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 89. Alimera Sciences Recent Developments

Table 90. Regeneron Pharmaceuticals Company Details

Table 91. Regeneron Pharmaceuticals Business Overview

Table 92. Regeneron Pharmaceuticals Diabetic Retinopathy Product

Table 93. Regeneron Pharmaceuticals Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 94. Regeneron Pharmaceuticals Recent Developments

Table 95. Boehringer Ingelheim Company Details

Table 96. Boehringer Ingelheim Business Overview

Table 97. Boehringer Ingelheim Diabetic Retinopathy Product

Table 98. Boehringer Ingelheim Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 99. Boehringer Ingelheim Recent Developments

Table 100. Kowa Group Company Details

Table 101. Kowa Group Business Overview

Table 102. Kowa Group Diabetic Retinopathy Product

Table 103. Kowa Group Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 104. Kowa Group Recent Developments

Table 105. Ohr Pharmaceutical Company Details

Table 106. Ohr Pharmaceutical Business Overview

Table 107. Ohr Pharmaceutical Diabetic Retinopathy Product

Table 108. Ohr Pharmaceutical Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 109. Ohr Pharmaceutical Recent Developments

Table 110. Quark Pharmaceuticals Company Details

Table 111. Quark Pharmaceuticals Business Overview

Table 112. Quark Pharmaceuticals Diabetic Retinopathy Product

Table 113. Quark Pharmaceuticals Revenue in Diabetic Retinopathy Business (2018-2023) & (US$ Million)

Table 114. Quark Pharmaceuticals Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Diabetic Retinopathy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Diabetic Retinopathy Market Share by Type: 2022 VS 2029

Figure 3. Laser Surgery Features

Figure 4. Injection of Corticosteroids Features

Figure 5. Anti-VEGF Drugs Features

Figure 6. Vitrectomy Features

Figure 7. Global Diabetic Retinopathy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 8. Global Diabetic Retinopathy Market Share by Application: 2022 VS 2029

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Others Case Studies

Figure 12. Diabetic Retinopathy Report Years Considered

Figure 13. Global Diabetic Retinopathy Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 14. Global Diabetic Retinopathy Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 15. Global Diabetic Retinopathy Market Share by Region: 2022 VS 2029

Figure 16. Global Diabetic Retinopathy Market Share by Players in 2022

Figure 17. Global Top Diabetic Retinopathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Retinopathy as of 2022)

Figure 18. The Top 10 and 5 Players Market Share by Diabetic Retinopathy Revenue in 2022

Figure 19. North America Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 20. North America Diabetic Retinopathy Market Share by Type (2018-2029)

Figure 21. North America Diabetic Retinopathy Market Share by Application (2018-2029)

Figure 22. North America Diabetic Retinopathy Market Share by Country (2018-2029)

Figure 23. United States Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 24. Canada Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 25. Europe Diabetic Retinopathy Market Size YoY (2018-2029) & (US$ Million)

Figure 26. Europe Diabetic Retinopathy Market Share by Type (2018-2029)

Figure 27. Europe Diabetic Retinopathy Market Share by Application (2018-2029)

Figure 28. Europe Diabetic Retinopathy Market Share by Country (2018-2029)

Figure 29. Germany Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. France Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. U.K. Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Italy Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. Russia Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Nordic Countries Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. China Diabetic Retinopathy Market Size YoY (2018-2029) & (US$ Million)

Figure 36. China Diabetic Retinopathy Market Share by Type (2018-2029)

Figure 37. China Diabetic Retinopathy Market Share by Application (2018-2029)

Figure 38. Asia Diabetic Retinopathy Market Size YoY (2018-2029) & (US$ Million)

Figure 39. Asia Diabetic Retinopathy Market Share by Type (2018-2029)

Figure 40. Asia Diabetic Retinopathy Market Share by Application (2018-2029)

Figure 41. Asia Diabetic Retinopathy Market Share by Region (2018-2029)

Figure 42. Japan Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. South Korea Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. China Taiwan Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Southeast Asia Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. India Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 47. Australia Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Diabetic Retinopathy Market Size YoY (2018-2029) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Diabetic Retinopathy Market Share by Type (2018-2029)

Figure 50. Middle East, Africa, and Latin America Diabetic Retinopathy Market Share by Application (2018-2029)

Figure 51. Middle East, Africa, and Latin America Diabetic Retinopathy Market Share by Country (2018-2029)

Figure 52. Brazil Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Mexico Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Turkey Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Israel Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 57. GCC Countries Diabetic Retinopathy Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 58. Bayer Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 59. Roche Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 60. Novartis Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 61. TEVA Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 62. Alimera Sciences Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 63. Regeneron Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 64. Boehringer Ingelheim Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 65. Kowa Group Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 66. Ohr Pharmaceutical Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 67. Quark Pharmaceuticals Revenue Growth Rate in Diabetic Retinopathy Business (2018-2023)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions